T-lymphocyte depleted transplants for inborn errors of immunity.

Published in: Expert review of clinical immunology (2023)

Pharmacokinetic monitoring of serotherapy agents, and use of co-stimulatory molecule blockade are likely to become more widespread. Post-transplant cyclophosphamide or TCR depletion strategies are likely to become the dominant methods of transplantation for nonmalignant diseases.

Keyphrases

regulatory t cells
low dose
high dose
peripheral blood
patient safety
adverse drug
cell therapy
emergency department
mesenchymal stem cells